essence semaglutide in MASH with F2-F3 fibrosis: a holistic perspective on the phase 3 trial Breaking! Phase 3 ESSENCE trial
Description
A good candidate for semaglutide is an adult with a BMI of 30 or higher or a BMI of 27 or higher with a weight-related condition such as high blood pressure or type 2 diabetes
Extend fasting intervals, use rapid-sequence induction when indicated, and consider preoperative gastric emptying assessment in high-risk patients
Long-Term Weight Management Adults who understand that sustainable weight loss requires medication strategy, nutrition, behavior, monitoring, and maintenance planning
Chemotherapy drug shortages in the United States: genesis and potential solutions
FDA.gov National Association of Boards of Pharmacy
